In collaboration with Fresh toast
Antiviral pills have been able to provide treatment for viruses such as HIV, influenza and more. The United States is now investing in a pill for COVID-19.
The COVID-19 vaccine was a world-class effort that resulted in the fastest vaccine ever made. The shooting stopped the door of the pandemic and allowed millions of people to feel safe and return to the feeling of normalcy.
Now that there is a vaccine that drastically reduces the chances of getting the disease, the U.S. government is interested in a pill that can treat COVID-19 infections.
As reported by the New York News, the US government is investing $ 3 billion in researching a pill to combat COVID-19. This funding will accelerate a program that will facilitate clinical trials of the pills that are in development, with the goal of having a first generation ready by the end of the year. The program will also work on developing pills that can treat other viruses and prevent future pandemics.
Antiviral pills are used to treat a wide variety of diseases such as HIV, influenza and more. Although there is a year of evidence and data to work with, for most of the pandemic doctors have had difficulty curing people sick with COVID-19.
Ideally, the pill would work when taken early in the progression of the disease, attacking the infection quickly and preventing it from spreading and spreading, which is when complications appear for most people. Still, despite the program’s promising pills, it’s hard to get a pill that works during the first trial, so experts believe it will take a couple of years to get a COVID-19 prescription that works.
The program would provide support for the development of pills that can treat coronaviruses, flaviviruses (transmitted mainly by ticks and mosquitoes) and more. Even if the pills are not effective immediately, they create bases that could help curb future pandemics and save millions of lives.
Read more Fresh toast